Ignite Creation Date:
2025-12-24 @ 9:47 PM
Ignite Modification Date:
2025-12-27 @ 1:15 PM
Study NCT ID:
NCT01836432
Status:
TERMINATED
Last Update Posted:
2020-05-28
First Post:
2013-04-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer
Sponsor:
NewLink Genetics Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-05
Start Date Type:
None
Primary Completion Date:
2016-07-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-03-24
Completion Date Type:
ACTUAL
First Submit Date:
2013-04-17
First Submit QC Date:
None
Study First Post Date:
2013-04-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2019-02-25
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2020-05-26
Last Update Post Date:
2020-05-28
Last Update Post Date Type:
ACTUAL